Abiopharma

🔍 Nieri Robyn (Executive)

Company: United Homes Group, Inc. (UHG)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Sold 1,121,328 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 400,000 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Pursuant to the Agreement and Plan of Merger, dated as of February 22, 2026 (the "Merger Agreement"), among the Issuer, Stanley Martin Homes, LLC ("Parent") and Union MergeCo, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (the "Merger") and each share of Class A Common Stock was canceled and converted into the right to receive cash in an amount equal to $1.18 per share, without interest thereon, less applicable tax withholding (the "Per Share Amount").
• F2: Consists of (i) 500,000 shares of Class A Common Stock directly owned by the reporting person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Exchange Act, and (ii) 621,328 shares of Class A Common Stock held in a joint account with the reporting person's spouse, who may also be deemed to be a member of the "group" for purposes of Section 13(d) of the Exchange Act.
• F3: Consists of 400,000 shares of Class A Common Stock owned by the reporting person's spouse.